Skip to content

EMPOWERing Patients With Chronic Diseases Through Smartphone App, Health Coaching and Shared Decision Making

EMPOWERing Patients With Chronic Diseases Through Smartphone App, Health Coaching and Shared Decision Making

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05486390
Enrollment
320
Registered
2022-08-03
Start date
2023-02-17
Completion date
2025-05-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Hypertension

Keywords

Nudge, Wearable, Behavioural change

Brief summary

Chronic diseases are the leading cause of deaths in Singapore. The rising prevalence in chronic diseases with age and Singapore's rapidly aging population calls for new models of care to effectively prevent the onset and delay the progression of these diseases. Advancement in medical technology has offered new innovations that aid healthcare systems in coping with the rapid rising in healthcare needs. These include mobile applications, wearable technologies and machine learning-derived personalized behaviorial interventions. The overall goal of the project is to improve health outcomes in chronic disease patients through delivering targeted nudges via mobile application and wearable to sustain behavioral change. Our overall objective is to design, develop, and evaluate an adaptive intervention platform on wearable devices and shared decision-making during consultations for patients with diabetes and hypertension. Our aim for this study is to assess the clinical effectiveness of real-time personalized educational and behavioural interventions delivered through wearable (Fitbit) and an integrative mobile application in improving patient glycaemic control measured using HbA1c over 9 months. Secondary outcomes will include change in systolic blood pressure, quality of life (QoL), patient activation, medication adherence, physical activity level, diet, direct healthcare cost and indirect healthcare cost over 9 months. We will conduct a randomized controlled trial among patients with comorbid diabetes and hypertension. This proposal aims to develop sustainable and cost-effective behavioural change among patients with comorbid diabetes and hypertension through patient empowerment and targeted chronic disease care.

Interventions

BEHAVIORALNudge, health coaching and shared decision-making

The EMPOWER app aims to nudge the participant towards successful self-management of their diabetes condition by encouraging and reinforcing positive lifestyle behaviors in 3 main aspects - diet, physical activity, medication adherence. Notifications included content based on behavioural change technique including feedback on performance, positive reinforcement, and prompts to self-monitor. Each notification focused on a single behaviour (physical activity, medication adherence or diet). The participants in the intervention group will also interact with health coach throughout the study duration. In this study, the health coach will be responsible for the following roles : 1. Goal setting and action plan 2. After-visit summary A report card summarizing the lifestyle behaviour, goals will be made available to facilitate shared decision making.

Sponsors

SingHealth Polyclinics
CollaboratorOTHER
National University of Singapore
CollaboratorOTHER
Duke-NUS Graduate Medical School
CollaboratorOTHER
Singapore General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 21 years old and above 2. Have been diagnosed with diabetes at time of recruitment 3. Most recent glycated haemoglobin (HbA1c) ≥ 7.0% 4. Systolic blood pressure≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg on two or more prior visits, physician-diagnosed hypertension, or on antihypertensive medication 5. Physically able to exercise 6. Literate in English 7. Agreeable to be monitored by EMPOWER and/or Fitbit apps 8. Able to conform to monitoring schedule

Exclusion criteria

1. On bolus insulin treatment 2. Require assistance with basic activities of daily living (BADL) 3. Have planned major operation or surgical procedure within next 9 months 4. Cognitively impaired (scored ≥ 6 on the Abbreviated Mental Test)

Design outcomes

Primary

MeasureTime frameDescription
HbA1c9 monthsHbA1c over 9 months

Secondary

MeasureTime frameDescription
Physical activity as measured by number of steps9 monthsPhysical activity over 9 months
Physical activity as measured by moderate to vigorous active minutes9 monthsPhysical activity over 9 months
Patient activation score as measured by patient activation measure9 monthsDifference in patient activation score between intervention and control over 9 months
Systolic blood pressure9 monthsSystolic blood pressure over 9 months
Quality of life as measured by EQ-5D-5L9 monthsDifference in quality of life between intervention and control over 9 months
Healthcare cost9 monthsHealthcare cost over 9 months
Medication adherence as measured by Voils Scale9 monthsDifference in medication adherence between intervention and control over 9 months

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026